Patients are our priority, so we make referring them simple.
At BrightView, we’re committed to connecting patients to the quality addiction treatment they need as quickly as possible. That’s why we view our referral partners as just that: partners. We work closely with our referral partners to expedite scheduling, streamline communication, and comply with patient privacy regulations.
Our clinical and medical teams are passionate about offering the highest level of patient-focused, evidence-based care. We continue to do so by contributing to and incorporating the latest research, technologies, and clinical concepts. At BrightView, we believe addiction is a disease we can treat using a biological, psychological, and sociological approach, also called the “biopsychosocial model.”
If you’re looking to refer a patient, become a provider, or learn more about an organization dedicated to helping people overcome addiction, look no further.
Consent for Release of Confidential Information
This form can be completed using a digital signature. The standard ROI may be used for any patient to consent for distribution of their treatment information to an assigned party.
Criminal Justice Consent for Release of Confidential Information
This form can be completed with a digital signature. It should be used only for patients involved in the criminal justice system, including court mandated treatment.
Schedule a Patient Now
Referring a patient to effective treatment should be simple and instantaneous.
Our Innovative Approach to Treatment
We have the experience and the expertise to treat addiction the right way. Learn what sets us apart.
For qualifying patients, a comprehensive addiction treatment program is available entirely online through BrightView Virtual.
Frequently Asked Questions
Still have questions about BrightView addiction treatment programs? Find those answers and more in our FAQs.
BrightView patients decrease use of illicit substances by nearly 70% on average within the first 90 days, with many patients achieving complete abstinence.
In the first 90 days, BrightView patients experience a decrease in arrests of nearly 60%. After one year in treatment, average number of arrests were down 93% compared to when patients first started.
Patients report a 1/3 decrease in emergency room visits after just 3 months and a 50% decrease after one year.